Lueangarun S, et al. - The effectiveness and complications of MAS063DP and 0.02% triamcinolone acetonide (TA) lotion for post-laser wound healing were assessed in this randomized controlled trial. In both MAS063DP and 0.02%, TA melanin index at day 30 was notably less than baseline. Good safety profiles and no serious adverse reactions were noted by both the treatments with post-inflammatory hyperpigmentation (PIH) in 50% of cases. MAS063DP could be an efficacious treatment post-laser wound healing and complications and was seen to be compatible with 0.02% TA.